Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CorMedix Inc.CRMD · Entity 5280 | Director | January 26, 2026 | January 27, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CorMedix Inc.
Report date January 26, 2026 · Filed January 27, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 68,926 |
Reported balance
After 2026-01-26 transaction · row 1
1 source rowRow 1 · 2026-01-26 · Grant · Acquired 30,453 · Balance 68,926 F1: These shares represent restricted stock units issued on January 26, 2026. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units will vest in full on January 26, 2027, subject to continued service on the vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares represent restricted stock units issued on January 26, 2026. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units will vest in full on January 26, 2027, subject to continued service on the vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 21, 2018 Filed Mar 22, 2018 16:01 UTC | CorMedix Inc. CRMD · Entity 5280 | Exercise / conversionCommon Stock | 15,357 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-18-002932 · section16.xml · nonDerivative · entry 1 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,409 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · date: These Restricted Stock Units were granted on 2/21/2017. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock vested in full on the first anniversary of the date of grant, which was February 21, 2018. F1 · price: These Restricted Stock Units were granted on 2/21/2017. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock vested in full on the first anniversary of the date of grant, which was February 21, 2018. Read SEC document |
| February 16, 2018 Filed Feb 20, 2018 16:03 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantRestricted Stock Units · Derivative | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-18-001717 · section16.xml · derivative · entry 4 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 4,000 shares Expires not disclosed F2 · derivative.exercise_price: These Restricted Stock Units were granted on 2/16/2018. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. F2 · derivative.exercise_date: These Restricted Stock Units were granted on 2/16/2018. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. F2 · derivative.expiration_date: These Restricted Stock Units were granted on 2/16/2018. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| February 16, 2018 Filed Feb 20, 2018 16:03 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantRestricted Stock Units · Derivative | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-18-001717 · section16.xml · derivative · entry 3 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires not disclosed F2 · derivative.exercise_price: These Restricted Stock Units were granted on 2/16/2018. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. F2 · derivative.exercise_date: These Restricted Stock Units were granted on 2/16/2018. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. F2 · derivative.expiration_date: These Restricted Stock Units were granted on 2/16/2018. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| February 16, 2018 Filed Feb 20, 2018 16:03 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantStock Option (Right to Buy Common Stock) · Derivative | 40,000 | $0.00 Strike: $0.57 | $0.00 |
DisclosureSEC source: 0001654954-18-001717 · section16.xml · derivative · entry 2 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2028-02-16 F1 · derivative.exercise_date: These options vest in full on the first anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| February 16, 2018 Filed Nov 30, 2018 16:10 UTC Amendment | CorMedix Inc. CRMD · Entity 5280 | GrantStock Option (Right to Buy Common Stock) · Derivative | 40,000 | $0.00 Strike: $0.57 | $0.00 |
DisclosureSEC source: 0001654954-18-013409 · section16.xml · derivative · entry 2 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2028-02-16 F2 · derivative.exercise_date: These options were granted on 2/16/2018. The options vest in full on the first anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| February 16, 2018 Filed Nov 30, 2018 16:10 UTC Amendment | CorMedix Inc. CRMD · Entity 5280 | GrantCommon Stock | 14,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001654954-18-013409 · section16.xml · nonDerivative · entry 1 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,052 F1 · price: These shares consist of restricted stock units granted on 2/16/2018. These restricted stock units will vest monthly with full vesting on the first anniversary of the date of grant, subject to continued service on the board. This amendment reports the restricted stock units in Table I rather than Table II as originally reported. Read SEC document |
| February 14, 2018 Filed Feb 15, 2018 16:02 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantPhantom Stock · Derivative | 13,392 | $0.56 Strike: $0.00 | $7,499.52 |
DisclosureSEC source: 0001654954-18-001607 · section16.xml · derivative · entry 2 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,392 Underlying: Common Stock · 13,392 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F1 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F1 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. Read SEC document |
| December 12, 2017 Filed Dec 14, 2017 16:13 UTC | CorMedix Inc. CRMD · Entity 5280 | PurchaseCommon Stock | 52,083 | $0.48 | $24,999.84 |
DisclosureSEC source: 0001654954-17-011655 · section16.xml · nonDerivative · entry 1 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,052 F1 · date: Purchase was contracted on November 17, 2017, but not closed until December 12, 2017. Read SEC document |
| November 14, 2017 Filed Nov 16, 2017 16:01 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantPhantom Stock · Derivative | 15,625 | $0.48 Strike: $0.00 | $7,500.00 |
DisclosureSEC source: 0001654954-17-010802 · section16.xml · derivative · entry 2 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,625 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F2 · shares: These shares were credited automatically to the reporting person's account pursuant to the reporting person's election to defer the receipt of cash compensation for director's fees. F1 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F1 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. Read SEC document |
| August 14, 2017 Filed Aug 24, 2017 07:42 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantPhantom Stock · Derivative | 20,833 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-17-007866 · section16.xml · derivative · entry 2 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,833 Underlying: Common Stock · 20,833 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F1 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F1 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. Read SEC document |
| May 15, 2017 Filed May 17, 2017 16:05 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantPhantom Stock · Derivative | 15,306 | $0.00 | $0.00 |
DisclosureSEC source: 0001354488-17-000512 · issuerdirect_section16.xml · derivative · entry 12 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,306 Underlying: Common Stock · 15,306 shares Expires not disclosed F4 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F4 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F4 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. Read SEC document |
| May 15, 2017 Filed May 17, 2017 16:05 UTC | CorMedix Inc. CRMD · Entity 5280 | PurchaseCommon Stock | 21,231 | $0.48 | $10,084.73 |
DisclosureSEC source: 0001354488-17-000512 · issuerdirect_section16.xml · nonDerivative · entry 1 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,969 F1 · price: This transaction was executed in multiple trades at prices ranging from $0.473 to $0.475. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 16:05 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantRestricted Stock Units · Derivative | 15,357 | $0.00 | $0.00 |
DisclosureSEC source: 0001354488-17-000308 · issuerdirect_section16.xml · derivative · entry 3 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,357 Underlying: Common Stock · 15,357 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. F2 · derivative.exercise_date: Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. F2 · derivative.expiration_date: Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. F2 · derivative.underlying_shares: Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 16:05 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantStock Option (Right to Buy Common Stock) · Derivative | 40,000 | $0.00 Strike: $2.24 | $0.00 |
DisclosureSEC source: 0001354488-17-000308 · issuerdirect_section16.xml · derivative · entry 2 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2027-02-21 F1 · derivative.exercise_date: The options vest in full on the first anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| February 14, 2017 Filed Feb 15, 2017 16:01 UTC | CorMedix Inc. CRMD · Entity 5280 | PurchasePhantom Stock · Derivative | 3,472 | $7,500.00 Strike: $0.00 | $26,040,000.00 |
DisclosureSEC source: 0001354488-17-000266 · issuerdirect_section16.xml · derivative · entry 2 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,472 Underlying: Common Stock · 3,472 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F2 · shares: These shares were credited automatically to the reporting person's account pursuant to the reporting person's election to defer the receipt of cash compensation for directors' fees. F1 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F1 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. Read SEC document |
| November 14, 2016 Filed Nov 16, 2016 16:05 UTC | CorMedix Inc. CRMD · Entity 5280 | PurchasePhantom Stock · Derivative | 4,143 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001354488-16-008518 · issuerdirect_section16.xml · derivative · entry 2 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,143 Underlying: Common Stock · 4,143 shares Expires not disclosed F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F2 · shares: These shares were credited automatically to the reporting person's account pursuant to the reporting person's election to defer the receipt of cash compensation for directors' fees. F1 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F1 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.